- Administration of isothiocyanate (E-4IB) and cisplatin leads to alter…
Number of the records: 1  

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells

  1. Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells / J. Duraj ... [et al.]. Neoplasma Vol. 56, no. 3 (2009), s. 208-214
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.